HomeCompareKNKT vs JNJ

KNKT vs JNJ: Dividend Comparison 2026

KNKT yields 1000000.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KNKT wins by $4.7683925249533696e+36M in total portfolio value
10 years
KNKT
KNKT
● Live price
1000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.7683925249533696e+36M
Annual income
$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00
Full KNKT calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — KNKT vs JNJ

📍 KNKT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKNKTJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KNKT + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KNKT pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KNKT
Annual income on $10K today (after 15% tax)
$85,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, KNKT beats the other by $4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KNKT + JNJ for your $10,000?

KNKT: 50%JNJ: 50%
100% JNJ50/50100% KNKT
Portfolio after 10yr
$2.3841962624766848e+36M
Annual income
$2,383,727,347,228,033,600,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

KNKT
No analyst data
Altman Z
-5.9
Piotroski
1/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KNKT buys
0
JNJ buys
0
No recent congressional trades found for KNKT or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKNKTJNJ
Forward yield1000000.00%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$4.7683925249533696e+36M$20.0K
Annual income after 10y$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00$827.78
Total dividends collected$4.7683311610149396e+36M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: KNKT vs JNJ ($10,000, DRIP)

YearKNKT PortfolioKNKT Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$100,010,700$100,000,000.00$10,676$355.77+$100.00MKNKT
2$934,786,450,701$934,679,439,252.34$11,407$389.39+$934786.44MKNKT
3$8,165,787,108,578,292$8,164,786,887,076,042.00$12,198$426.53+$8165787108.57MKNKT
4$66,665,884,190,957,650,000$66,657,146,798,751,470,000.00$13,056$467.62+$66665884190957.63MKNKT
5$508,662,171,058,048,100,000,000$508,590,838,561,963,700,000,000.00$13,987$513.12+$508662171058048128.00MKNKT
6$3,627,235,248,428,489,700,000,000,000$3,626,690,979,905,457,600,000,000,000.00$14,998$563.56+$3.62723524842849e+21MKNKT
7$24,173,681,159,150,610,000,000,000,000,000$24,169,800,017,434,790,000,000,000,000,000.00$16,098$619.52+$2.417368115915061e+25MKNKT
8$150,567,402,861,454,640,000,000,000,000,000,000$150,541,537,022,614,370,000,000,000,000,000,000.00$17,295$681.69+$1.5056740286145463e+29MKNKT
9$876,477,100,281,847,600,000,000,000,000,000,000,000$876,315,993,160,785,800,000,000,000,000,000,000,000.00$18,599$750.82+$8.764771002818475e+32MKNKT
10$4,768,392,524,953,369,600,000,000,000,000,000,000,000,000$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00$20,022$827.78+$4.7683925249533696e+36MKNKT

KNKT vs JNJ: Complete Analysis 2026

KNKTStock

Kunekt Corporation does not have significant operations. The company intends to acquire or merge with an established business. Previously, it focused on designing, building, and marketing mobile phones, smartphones, and tablets. The company was founded in 2007 and is based in Carson City, Nevada.

Full KNKT Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this KNKT vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KNKT vs SCHDKNKT vs JEPIKNKT vs OKNKT vs KOKNKT vs MAINKNKT vs ABBVKNKT vs MRKKNKT vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.